STOCK TITAN

LifeMD 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Net Income by Year

LFMDP NASDAQ

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock reported $14.4M in net income in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $201K in net income. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock has filed alongside them.

FY2025 annual
Net Income $14.4M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LFMDP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18FilingFY17FilingFY16FilingFY15FilingFY14FilingFY13FilingFY12Filing
Net Income$201K$14.4Mn/m-$21.4Mn/m-$20.6Mn/m-$45.5Mn/m-$60.9Mn/m-$58.6Mn/m-$3.1Mn/m-$1.2Mn/m-$1.2Mn/m-$1.1Mn/m-$62Kn/m-$460Kn/m-$268Kn/m-$446K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

LFMDP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'25FilingQ2'2510-QQ1'2510-QQ4'24FilingQ3'24FilingQ2'2410-QQ1'24FilingQ4'23FilingQ3'23Filing
Net Income-$7.1Mn/m-$8.9Mn/m$20.0Mn/m-$3.8Mn/m-$1.6Mn/m-$184Kn/m-$4.9Mn/m-$4.7Mn/m-$6.9Mn/m-$6.8Mn/m-$3.7Mn/m-$6.1Mn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock financials

Frequently Asked Questions

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock reported $14.4M in net income in fiscal year 2025.

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported a $21.4M net loss in fiscal year 2024 and $14.4M in net income in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported $201K in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 14 fiscal years this page covers, LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) net income went from -$446K in fiscal year 2012 to $14.4M in fiscal year 2025.

LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported -$7.1M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) reported on that line in every period on record.